Priming technique can alleviate the withdrawal responses associated with intravenous administration of rocuronium

다국어 초록 (Multilingual Abstract)

Background: Intravenous injection of rocuronium is associated with withdrawal responses which are attributable to the pain from the injection of rocuronium. Several methods have been proposed to abolish and attenuate rocuronium-induced pain. We hypothesized priming dose of rocuronium could reduce withdrawal responses associated with administering a second large dose of rocuronium for tracheal intubation. We compared the efficacy of the priming dose technique of rocuronium with intravenous lidocaine as a pre-treatment for the prevention of withdrawal responses associated with rocuronium injection.
Methods: We recruited 150 patients aged between 18 and 60 years, ASA physical status 1 or 2, who were going to undergo elective surgery requiring general anesthesia. Patients were allocated into three groups. Group C received normal saline, Group L received lidocaine 1 mg/kg, and Group P received rocuronium 0.06 mg/kg 2 minutes before administering a second large dose of rocuronium for tracheal intubation. After the loss of consciousness, rocuronium 0.6 mg/kg was administered intravenously over 10 seconds for tracheal intubation. The withdrawal responses to the injection of rocuronium were evaluated.
Results: The incidence of withdrawal responses associated with rocuronium injection for tracheal intubation was 56, 50, 24% in group C, group L, and group P, respectively. The incidence of withdrawal responses was lower in group P than group C and group L, but there was no difference between group L and group C.
Conclusions: Priming dose technique is a useful clinical method to alleviate withdrawal responses associated with rocuronium injection.

참고문헌 (Reference)

1 Ruetsch YA, "Withdrawal movements associated with the injection of rocuronium" 90 : 227-228, 2000

2 Hofmockel R, "Time-course of action and intubating conditions with rocuronium bromide under propofol-alfentanil anaesthesia" 11 : 69-72, 1995

3 Shevchenko Y, "The use of lidocaine for preventing the withdrawal associated with the injection of rocuronium in children and adolescents" 88 : 746-748, 1999

4 Jones RM, "The priming principle: how does it work and should we be using it?" 63 : 1-3, 1989

5 Memiş D, "The prevention of pain from injection of rocuronium by ondansetron, lidocaine, tramadol, and fentanyl" 94 : 1517-1520, 2002

6 Turan A, "The prevention of pain from injection of rocuronium by magnesium sulphate, lignocaine, sodium bicarbonate and alfentanil" 31 : 277-281, 2003

7 Mencke T, "Spontaneous movements, local reactions and pain on injection of rocuronium. A comparison between female and male patients" 45 : 1002-1005, 2001

8 Borgeat A, "Spontaneous movements associated with rocuronium: is pain on injection the cause?" 79 : 382-383, 1997

9 Lui JT, "Rocuronium-induced generalized spontaneous movements cause pulmonary aspiration" 25 : 617-620, 2002

10 Abdulatif M, "Rocuronium priming of atracurium-induced neuromuscular blockade: the use of short priming intervals" 8 : 376-381, 1996

11 Foldes F, "Rapid tracheal intubation with non-depolarizing neuromuscular blocking drugs: the priming principle" 56 : 663-, 1984

12 Scott RP, "Propofol: clinical strategies for preventing the pain of injection" 43 : 492-494, 1988

13 Oh AY, "Prevention of withdrawal movement associated with injection of rocuronium in children: comparison of remifentanil, alfentanil and fentanyl" 51 : 1190-1193, 2007

14 Kim KS, "Prevention of withdrawal associated with the injection of rocuronium in adults and children" 18 : 334-338, 2006

15 Ahmad N, "Preventing the withdrawal response associated with rocuronium injection: a comparison of fentanyl with lidocaine" 100 : 987-990, 2005

16 Liou JT, "Pretreatment with small-dose ketamine reduces withdrawal movements associated with injection of rocuronium in pediatric patients" 97 : 1294-1297, 2003

17 Engbaek J, "Precurarization with vecuronium and pancuronium in awake, healthy volunteers: the influence on neuromuscular transmission and pulmonary function" 29 : 117-120, 1985

18 Cheong KF, "Pain on injection of rocuronium: influence of two doses of lidocaine pretreatment" 84 : 106-107, 2000

19 Steegers MA, "Pain on injection of rocuronium bromide" 83 : 203-, 1996

20 Joshi GP, "Pain on injection of rocuronium bromide" 84 : 228-, 1997

21 Arndt JO, "Pain evoked by polymodal stimulation of hand veins in humans" 440 : 467-478, 1991

22 Wright PM, "Onset and duration of rocuronium and succinylcholine at the adductor pollicis and laryngeal adductor muscles in anesthetized humans" 81 : 1110-1115, 1994

23 Blunk JA, "Injection pain of rocuronium and vecuronium is evoked by direct activation of nociceptive nerve endings" 20 : 245-253, 2003

24 Reddy MS, "Effect of ondansetron pretreatment on pain after rocuronium and propofol injection: a randomised, double-blind controlled comparison with lidocaine" 56 : 902-905, 2001

25 Tuncali BKA, "Dilution of rocuronium to 0.5 mg/ml with 0.9% NaCl eliminates the pain during intravenous injection in awake patients" 99 : 740-743, 2004

26 Naguib M, "Different priming techniques, including mivacurium, accelerate the onset of rocuronium" 41 : 902-907, 1994

27 Chiarella AB, "Comparison of four strategies to reduce the pain associated with intravenous administration of rocuronium" 90 : 377-379, 2003

28 Robertson EN, "A comparison of rocuronium and vecuronium: the pharmacodynamic, cardiovascular and intra-ocular effects" 9 : 116-121, 1994